Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3

CONTEXT: Current GH therapy requires daily injections, which can be burdensome. Somapacitan is a long-acting GH derivative in development for treatment of GH deficiency (GHD). OBJECTIVE: Evaluate the efficacy, safety, and tolerability of once-weekly somapacitan after 3 years of treatment. DESIGN: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Sävendahl, Lars, Battelino, Tadej, Højby Rasmussen, Michael, Brod, Meryl, Saenger, Paul, Horikawa, Reiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016428/
https://www.ncbi.nlm.nih.gov/pubmed/34964458
http://dx.doi.org/10.1210/clinem/dgab928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016428/
https://www.ncbi.nlm.nih.gov/pubmed/34964458
http://dx.doi.org/10.1210/clinem/dgab928

Ejemplares similares